Occult hepatitis B virus infection in a North American adult hemodialysis patient population
暂无分享,去创建一个
Manna Zhang | G. Minuk | A. Giulivi | C. Osiowy | D. Sun | J. Uhanova | K. Hawkins | A. Gutkin | K. Bernstein | R. Greenberg
[1] F. Zoulim,et al. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays , 2004, Journal of medical virology.
[2] M. Alter,et al. National surveillance of dialysis-associated diseases in the United States, 2001. , 2004, Seminars in dialysis.
[3] J. Desenclos,et al. Six years of sentinel surveillance of hepatitis B in general practice in France , 1998, European Journal of Epidemiology.
[4] Manna Zhang,et al. Rapid detection of hepatitis B virus mutations using real‐time PCR and melting curve analysis , 2002, Hepatology.
[5] J. Marrugat,et al. Prevalencia de las hepatitis B y C en diversas comarcas de Cataluña: estudio transversal , 2002 .
[6] R. Solà,et al. Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study: cross-sectional study , 2002 .
[7] G. Minuk,et al. Chronic hepatitis B infection in Canada. , 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[8] G. Lau,et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers , 2001, Hepatology.
[9] M. Alter,et al. Infection control in hemodialysis units. , 2001, Infectious disease clinics of North America.
[10] C. Bréchot,et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? , 2001, Hepatology.
[11] U. Binswanger,et al. [Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland]. , 2000, Schweizerische medizinische Wochenschrift.
[12] S. Locarnini,et al. Antiviral chemotherapy for the treatment of hepatitis B virus infections. , 2000, Gastroenterology.
[13] H. Marusawa,et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. , 1998, Transplantation.
[14] A. Lok,et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.
[15] M. Alter,et al. National surveillance of dialysis associated diseases in the United States, 1995. , 1998, ASAIO journal.
[16] R. Wiesner,et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.
[17] J. Bartolomé,et al. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. , 1997, Journal of the American Society of Nephrology : JASN.
[18] D. Samuel,et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. , 1997, Journal of hepatology.
[19] M. Sata,et al. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan. , 1996, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.
[20] G. Sunder-Plassmann,et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. , 1995, Kidney international.
[21] J. Emond,et al. The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors , 1995, Transplantation.
[22] H. Okamoto,et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.
[23] L. Ferrell,et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients , 1994, The Lancet.
[24] P. Grob,et al. Detection of HBs antigen in "anti-HBc alone" positive sera. , 1994, Journal of hepatology.
[25] I. Lauder,et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. , 1992, Gastroenterology.
[26] J. Sninsky,et al. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis , 1992, Transfusion.
[27] M. Alter,et al. Hemodialysis‐Associated Hepatitis B: Revised Recommendations for Serologic Screening , 1990 .
[28] A. Zuckerman,et al. Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.
[29] K. Isselbacher,et al. Rapid identification of low level hepatitis B-related viral genome in serum. , 1989, The Journal of clinical investigation.
[30] C. Bréchot,et al. TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS , 1988, The Lancet.
[31] K. Isselbacher,et al. Detection of hepatitis B virus infection in hepatitis B surface antigen-negative hemodialysis patients by monoclonal radioimmunoassays. , 1986, Gastroenterology.
[32] K. Isselbacher,et al. Identification and transmission of hepatitis B virus-related variants. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[33] W. Szmuness,et al. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. , 1984, The New England journal of medicine.
[34] M. Alter,et al. Cost benefit of vaccination for hepatitis B in hemodialysis centers. , 1983, The Journal of infectious diseases.
[35] H. Conn,et al. Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. , 1976, Annals of internal medicine.